Advisory Services Network’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Advisory Services Network’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6	Closed	-$251	–	3846
2023 Q4	$251	Buy	+6	New	+$221	﹤0.01%	3709
2018 Q2	–	Sell	-1,132	Closed	-$112K	–	2731
2018 Q1	$112K	Hold	1,132	–	–	0.01%	985
2017 Q4	$119K	Sell	1,132 -1,920	-63%	-$211K	0.01%	933
2017 Q3	$344K	Sell	3,052 -2,422	-44%	-$264K	0.04%	492
2017 Q2	$613K	Buy	5,474 +105	+2%	+$11.9K	0.08%	328
2017 Q1	$626K	Buy	+5,369	New	+$594K	0.09%	292
2016 Q3	$633K	Buy	5,729 +217	+4%	+$28.7K	0.12%	237
2016 Q2	$803K	Buy	5,512 +10	+0.2%	+$1.42K	0.18%	144
2016 Q1	$788K	Hold	5,502	–	–	0.22%	120
2015 Q4	$850K	Sell	5,502 -500	-8%	-$73K	0.27%	87
2015 Q3	$858K	Buy	+6,002	New	+$839K	0.26%	78

Other funds holding TARO

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Advisory Services Network's TARO Position: Q1 2024 in Review

Advisory Services Network sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 6 shares — an estimated $251 sold.

Advisory Services Network first reported a position in TARO in Q3 2015 and held it in 11 quarters. The position peaked at $858K in Q3 2015. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

Advisory Services Network reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 6 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $251.
Advisory Services Network first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2015 and held it in 11 quarters.
Advisory Services Network's Taro Pharmaceutical Industries Ltd. position peaked at $858K in Q3 2015.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.